Biotech News

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LeMaitre Vascular (LMAT)LeMaitre VascularConference / presentation

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 [email protected]

Related news

LeMaitre Vascular

Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological...

Recent company news

Stock data

Close
79.05 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States